BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Bonilla L, Espina M, Severino P, Cano A, Ettcheto M, Camins A, García ML, Souto EB, Sánchez-López E. Lipid Nanoparticles for the Posterior Eye Segment. Pharmaceutics 2021;14:90. [PMID: 35056986 DOI: 10.3390/pharmaceutics14010090] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 2.5] [Reference Citation Analysis]
Number Citing Articles
1 Li W, Chen L, Gu Z, Chen Z, Li H, Cheng Z, Li H, Zou L. Co-delivery of microRNA-150 and quercetin by lipid nanoparticles (LNPs) for the targeted treatment of age-related macular degeneration (AMD). J Control Release 2023;355:358-70. [PMID: 36738972 DOI: 10.1016/j.jconrel.2023.01.080] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
2 Luiz H, Oliveira Pinho J, Gaspar MM. Advancing Medicine with Lipid-Based Nanosystems-The Successful Case of Liposomes. Biomedicines 2023;11. [PMID: 36830971 DOI: 10.3390/biomedicines11020435] [Reference Citation Analysis]
3 González-Fernández FM, Delledonne A, Nicoli S, Gasco P, Padula C, Santi P, Sissa C, Pescina S. Nanostructured Lipid Carriers for Enhanced Transscleral Delivery of Dexamethasone Acetate: Development, Ex Vivo Characterization and Multiphoton Microscopy Studies. Pharmaceutics 2023;15. [PMID: 36839729 DOI: 10.3390/pharmaceutics15020407] [Reference Citation Analysis]
4 Xu X, Zuo YY. Nanomedicine for Ocular Drug Delivery. Nanomedicine 2023. [DOI: 10.1007/978-981-16-8984-0_32] [Reference Citation Analysis]
5 Esteruelas G, Souto EB, Espina M, García ML, Świtalska M, Wietrzyk J, Gliszczyńska A, Sánchez-López E. Diclofenac Loaded Biodegradable Nanoparticles as Antitumoral and Antiangiogenic Therapy. Pharmaceutics 2022;15. [PMID: 36678731 DOI: 10.3390/pharmaceutics15010102] [Reference Citation Analysis]
6 Kalita T, Dezfouli SA, Pandey LM, Uludag H. siRNA Functionalized Lipid Nanoparticles (LNPs) in Management of Diseases. Pharmaceutics 2022;14. [PMID: 36432711 DOI: 10.3390/pharmaceutics14112520] [Reference Citation Analysis]
7 Vasam M, Goulikar RK. Approaches for designing and delivering solid lipid nanoparticles of distinct antitubercular drugs. Journal of Biomaterials Science, Polymer Edition 2022. [DOI: 10.1080/09205063.2022.2144791] [Reference Citation Analysis]
8 Afarid M, Mahmoodi S, Baghban R. Recent achievements in nano-based technologies for ocular disease diagnosis and treatment, review and update. J Nanobiotechnology 2022;20:361. [PMID: 35918688 DOI: 10.1186/s12951-022-01567-7] [Reference Citation Analysis]
9 Akbari J, Saeedi M, Ahmadi F, Hashemi SMH, Babaei A, Yaddollahi S, Rostamkalaei SS, Asare-addo K, Nokhodchi A. Solid lipid nanoparticles and nanostructured lipid carriers: A review of the methods of manufacture and routes of administration. Pharmaceutical Development and Technology. [DOI: 10.1080/10837450.2022.2084554] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
10 Wu B, Feng J, Zeng T, Guo Q, Zhang Z, Ding C, Tian B, Sai S. Flurbiprofen loaded thermosensitive nanohydrogel for ophthalmic anti-inflammatory therapy. Journal of Drug Delivery Science and Technology 2022. [DOI: 10.1016/j.jddst.2022.103253] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
11 Xu X, Zuo YY. Nanomedicine for Ocular Drug Delivery. Nanomedicine 2022. [DOI: 10.1007/978-981-13-9374-7_32-1] [Reference Citation Analysis]